Hanna Björck
Senior Research Specialist
| Docent
E-mail: hanna.bjorck@ki.se
Visiting address: BioClinicum, Plan 8,Karolinska Universitetssjukhuset Solna, 17176 Stockholm
Postal address: K2 Medicin, Solna, K2 Kardiov m Olofsson P Björck H, 171 77 Stockholm
About me
- I’m a senior research specialist and team leader within the Division of
Cardiovascular Medicine, Dept of Medicine, Solna. I’m involved in several
research projects at Karolinska Institutet and the Karolinska University
Hospital with the overarching aim of understanding the underlying
pathological and molecular mechanism of aneurysmal disease. I did my Ph.D.
with Professor Toste Länne at the Department of Medical and Health Sciences
at Linköping University where I focused on vessel wall integrity in relation
to flow-disturbances and genetics. I have continued along this path and
today, I'm specifically interest in mechanisms underlying endothelial
integrity and flow-dependent vascular effects in the pathology of ascending
aortic aneurysm.
Postdoctoral Fellow. Atherosclerosis Research Unit, Department of Medicine
Solna, Karolinska Institutet, Stockholm, Sweden. March 2012 – 2016.
Ph.D. in Physiology, January 2012. Division of Cardiovascular Medicine,
Department of Medical and Health Sciences, Linköping University, Linköping,
Sweden.
M.Sc. in Molecular Biology, 2006, Uppsala University
Research
- The long-term interest of my team is to investigate the pathological and
molecular mechanism underlying aneurysmal disease. Specifically, we focus on
ascending aortic aneurysms (AscAA), both degenerative forms and aneurysm
occurring in association with bicuspid aortic valve disease, with specific
interest in endothelial integrity and flow-dependent vascular effects. Our
studies are translational and includes epidemiological studies on a large and
unique patient cohort, combined with molecular /in vitro/ using modern
techniques.
Ascending aortic aneurysm (AscAA) is a silent disease and a potentially fatal
condition if aortic wall rupture or dissection occurs. AscAA entails
destructive changes of the medial layer of the aortic wall but the precise
pathogenic mechanism behind its development is unclear. The most significant
risk factor for AscAA formation, however, is being born with a bicuspid
aortic valve (BAV), with as many as 50% of all BAV patients requiring
ascending aortic surgical repair at some point during their lifetime. BAV is
the most common congenital heart malformation with a prevalence of 0.5-1.5%.
A unique clinical cohort is the basis for our research, which aims to clarify
the disease mechanisms underlying aortic aneurysm formation. Our biobank
includes > - 2100 patients undergoing valve replacement and/or repair of the
ascending aorta, and today, our cohort is one of the largest and most
comprehensive in the world. The biobank consists of DNA, plasma, serum, and
tissue biopsies from all patients. Uniquely, we have collected biopsies from
multiple tissues from the same individual of the first 600 patients
(ascending aorta, internal thoracic artery, heart, and liver). Also, smooth
muscle cells and endothelial cells from patient ascending aortas have been
isolated for functional in vitro studies. We integrate multiomic analysis,
epidemiology, and genetics to identify candidategenes and pathways.
Functional evaluations are performed using cell culture and in vitro
analyses.
Teaching
- Course director, "Molecular Medicine - Cardiometabolic and Infectious
Diseases” (1BI048),
Lecturer on undergraduate and PhD courses at the Department of Medicine,
Solna.
Main supervisor for of Ph.D. students.
Articles
-
Article: JOURNAL OF MOLECULAR MEDICINE-JMM. 2023;101(10):1323-1333
-
Article: CLINICAL PROTEOMICS. 2023;20(1):31
-
Article: JOURNAL OF MOLECULAR MEDICINE-JMM. 2023;101(7):801-811
-
Article: ANNALS OF THORACIC SURGERY. 2022;114(5):1665-1670
-
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2022;11(9):e024346
-
Article: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2022;61(2):388-392
-
Article: JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE. 2021;8(11):143
-
Article: OPEN HEART. 2021;8(2):e001857
-
Article: BIORESEARCH OPEN ACCESS. 2020;9(1):269-278
-
Article: CIRCULATION RESEARCH. 2020;127(10):1261-1273
-
Article: NATURE GENETICS. 2019;51(1):42-50
-
Article: JOURNAL OF INTERNAL MEDICINE. 2019;285(1):102-114
-
Article: BLOOD. 2018;132(17):1842-1850
-
Article: ATHEROSCLEROSIS SUPPLEMENTS. 2018;35:e6-e13
-
Article: SCIENTIFIC REPORTS. 2018;8(1):2777
-
Article: FRONTIERS IN PHYSIOLOGY. 2017;8:400
-
Article: SCIENTIFIC REPORTS. 2016;6:35712
-
Article: IJC HEART AND VASCULATURE. 2016;11:74-79
-
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2015;35(4):973-980
-
Article: ANNALS OF THORACIC SURGERY. 2014;98(1):65-71
-
Article: AORTA. 2013;1(1):13-22
-
Article: JOURNAL OF MOLECULAR MEDICINE-JMM. 2013;91(1):129-139
-
Article: PLOS ONE. 2012;7(12):e52227
-
Article: JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. 2011;12(3):281-289
-
Article: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2011;42(3):309-316
-
Article: AMERICAN JOURNAL OF HYPERTENSION. 2011;24(7):802-808
-
Article: JOURNAL OF INTERNAL MEDICINE. 2009;265(3):373-381
-
Article: ATHEROSCLEROSIS. 2009;202(2):415-423
- Show more
All other publications
-
Preprint: MEDRXIV. 2024;MEDRXIV
-
Review: FRONTIERS IN CARDIOVASCULAR MEDICINE. 2019;6:182
-
Corrigendum: FRONTIERS IN PHYSIOLOGY. 2017;8:730
Employments
- Senior Research Specialist, Department of Medicine, Karolinska Institutet, 2021-
Degrees and Education
- Docent, Karolinska Institutet, 2022